Stockreport

Zosano Pharma issues new U.S. patent covering M207 as an acute treatment for migraine [Seeking Alpha]

Zosano Pharma Corporation  (ZSAN) 
Last zosano pharma corporation earnings: 11/9 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.zosanopharma.com
PDF Zosano Pharma issues new U.S. patent covering M207 as an acute treatment for migraineZosano Pharma (NASDAQ:ZSAN)announces that its previous patent application titled “Me [Read more]